Caseware UK (AP4) 2023.0.135 2023.0.135 2023-11-302023-11-302022-12-01falseThe principal activity of the Company is the research, development and provision of Ai based software andtechnology to enable cancer patients to to report and monitor their treatment.2720truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 11672175 2022-12-01 2023-11-30 11672175 2021-12-01 2022-11-30 11672175 2023-11-30 11672175 2022-11-30 11672175 c:Director7 2022-12-01 2023-11-30 11672175 d:OfficeEquipment 2022-12-01 2023-11-30 11672175 d:OfficeEquipment 2023-11-30 11672175 d:OfficeEquipment 2022-11-30 11672175 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 11672175 d:ComputerEquipment 2022-12-01 2023-11-30 11672175 d:ComputerEquipment 2023-11-30 11672175 d:ComputerEquipment 2022-11-30 11672175 d:ComputerEquipment d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 11672175 d:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 11672175 d:CurrentFinancialInstruments 2023-11-30 11672175 d:CurrentFinancialInstruments 2022-11-30 11672175 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 11672175 d:CurrentFinancialInstruments d:WithinOneYear 2022-11-30 11672175 d:ShareCapital 2023-11-30 11672175 d:ShareCapital 2022-11-30 11672175 d:SharePremium 2023-11-30 11672175 d:SharePremium 2022-11-30 11672175 d:RetainedEarningsAccumulatedLosses 2023-11-30 11672175 d:RetainedEarningsAccumulatedLosses 2022-11-30 11672175 c:OrdinaryShareClass1 2022-12-01 2023-11-30 11672175 c:OrdinaryShareClass1 2023-11-30 11672175 c:OrdinaryShareClass1 2022-11-30 11672175 c:OrdinaryShareClass2 2022-12-01 2023-11-30 11672175 c:OrdinaryShareClass2 2023-11-30 11672175 c:OrdinaryShareClass3 2022-12-01 2023-11-30 11672175 c:OrdinaryShareClass3 2023-11-30 11672175 c:FRS102 2022-12-01 2023-11-30 11672175 c:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 11672175 c:FullAccounts 2022-12-01 2023-11-30 11672175 c:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 11672175 e:PoundSterling 2022-12-01 2023-11-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11672175









VINEHEALTH DIGITAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2023

 
VINEHEALTH DIGITAL LIMITED
REGISTERED NUMBER: 11672175

BALANCE SHEET
AS AT 30 NOVEMBER 2023

2023
2023
2022
2022
Note
£
£
£
£

FIXED ASSETS
  

Tangible assets
 4 
7,005
22,927

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
106,986
212,312

Cash at bank and in hand
  
404,045
2,249,936

  
511,031
2,462,248

Creditors: amounts falling due within one year
 6 
(235,007)
(256,632)

NET CURRENT ASSETS
  
 
 
276,024
 
 
2,205,616

  

NET ASSETS
  
283,029
2,228,543


CAPITAL AND RESERVES
  

Called up share capital 
 7 
167
167

Share premium account
  
5,282,972
5,281,981

Profit and loss account
  
(5,000,110)
(3,053,605)

  
283,029
2,228,543

Page 1

 
VINEHEALTH DIGITAL LIMITED
REGISTERED NUMBER: 11672175
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




D S Gibson
Director

Date: 19 August 2024

The notes on pages 3 to 8 form part of these financial statements.
Page 2

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

1.


GENERAL INFORMATION

Vinehealth Digital Limited is a private company limited by shares and was incorporated in England and Wales. Its registered office address is 107 Station Street, Burton-On-Trent, Staffordshire, DE14 1SZ.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

The financial statements have been prepared on the going concern basis which assumes that the Company will continue as a going concern for the foreseeable future. The trading losses reported to date are consistent with the Company's business plan as it progresses its research and development activities.
Given the investment received, together with the development progress achieved, the directors have a reasonable expectation that the Company will be able to meet its liabilities as they fall due for the foreseeable future and therefore continue to adopt the going concern basis.

 
2.3

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

TURNOVER

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

GOVERNMENT GRANTS

Grants are accounted under the accruals model as permitted by FRS 102.
Grants of a revenue nature are recognised in the Profit and Loss Account in the same period as the related expenditure.

 
2.6

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN 

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

2.ACCOUNTING POLICIES (CONTINUED)

 
2.7

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.
Deferred tax balances are not recognised in respect of permanent differences.  Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.8

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
3 years
Computer equipment
-
3 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

DEBTORS

Short term debtors are measured at transaction price, less any impairment. 

Page 5

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

2.ACCOUNTING POLICIES (CONTINUED)

 
2.10

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 27 (2022 - 20).


4.


TANGIBLE FIXED ASSETS





Office equipment
Computer equipment
Total

£
£
£



COST OR VALUATION


At 1 December 2022
163
37,585
37,748


Additions
-
3,143
3,143


Disposals
-
(23,906)
(23,906)



At 30 November 2023

163
16,822
16,985



DEPRECIATION


At 1 December 2022
46
14,775
14,821


Charge for the year on owned assets
40
6,546
6,586


Disposals
-
(11,427)
(11,427)



At 30 November 2023

86
9,894
9,980



NET BOOK VALUE



At 30 November 2023
77
6,928
7,005



At 30 November 2022
117
22,810
22,927

Page 6

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

5.


DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2023
2022
£
£


Trade debtors
41,096
156,000

Other debtors
13,403
23,423

Called up share capital not paid
-
5

Prepayments and accrued income
52,487
32,884

106,986
212,312



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2023
2022
£
£

Trade creditors
28,885
45,490

Other taxation and social security
42,690
66,254

Other creditors
-
8,602

Accruals and deferred income
163,432
136,286

235,007
256,632



7.


SHARE CAPITAL

2023
2022
£
£
ALLOTTED, CALLED UP AND FULLY PAID



13,137,891 (2022 - 12,609,438) Odinary shares of £0.00001 each
131
126
668,854 Seed 1 shares of £0.00001 each
7
7
2,921,969 Seed 2 shares of £0.00001 each
29
29

167

162

ALLOTTED, CALLED UP AND UNPAID



NIL (2022 - 527,476 Odinary shares of £0.00001 each
-
5


On 26 April 2023 the Company issued 2,916 Ordinary shares of £0.00001 each at a rate of £0.34 per share.

Page 7

 
VINEHEALTH DIGITAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

8.


CONTINGENT LIABILITIES

A contingent liability has been identified relating to two contracts with GlaxoSmithKline Research & Development Limited (dated November 2022 & December 2022). The potential termination of these agreements would result in a cost of between £100,000 and £200,000. At the balance sheet date, discussions were still in the early stages, as such a provision has not been made.

 
Page 8